Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:investigational_medication |
| gptkbp:actsOn |
gptkb:orexin_receptor_antagonist
|
| gptkbp:ATCCode |
N05CM22
|
| gptkbp:CASNumber |
2015947-76-2
|
| gptkbp:chemicalFormula |
C20H20N4O
|
| gptkbp:developedBy |
gptkb:Minerva_Neurosciences
gptkb:Janssen_Pharmaceuticals |
| gptkbp:hasUNII |
6Q1K1Q1K0E
|
| gptkbp:investigatedBy |
gptkb:major_depressive_disorder
insomnia |
| gptkbp:isNotYetApprovedForUse |
gptkb:European_Union
gptkb:United_States |
| gptkbp:molecularWeight |
332.4 g/mol
|
| gptkbp:PubChem_CID |
121489382
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
JNJ-42847922
MIN-202 |
| gptkbp:target |
orexin OX2 receptor
|
| gptkbp:bfsParent |
gptkb:Minerva_Neurosciences
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
seltorexant
|